The FDA announced on July 8, 2021, that Vascutek, Ltd. recalled The Instructions for Use (IFU) for Gelsoft Plus Bifurcate, Gelsoft Plus Ax-Fem, GelsoftPlus ERS Ax-Fem, and Gelweave vascular grafts because the devices contained IFUs intended for rest of world consignees rather than U.S. consignees.
How to tell if you have it
- Vascutek Terumo Gelsoft Gelatin Impregnated Knitted Vascular Prosthesis, Bifurcate, REF 631408
- Vascutek Terumo Gelsoft Gelatin Impregnated Knitted Vascular Prosthesis, Bifurcate, REF 631608
- Vascutek Terumo Gelsoft Gelatin Impregnated Knitted Vascular Prosthesis, Bifurcate, REF 631809
- Vascutek Terumo Gelsoft Gelatin Impregnated Knitted Vascular Prosthesis, Bifurcate, REF 632010
- Vascutex Terumo Gelsoft Gelatin Impregnated Knitted Vascular Prosthesis, Bifurcate, REF 632211
The hazard
The recalled vascular grafts contained the Instructions for Use (IFU) for distribution to rest of world consignees rather than U.S. consignees.
Context
GovInfoNow's records show Vascutek, Ltd. has one other recall on record since 2025-12-18 involving incorrect shelf life labeling for Gelsoft Plus and Gelweave devices. Other recent recalls of similar products include Boston Scientific FARASTAR Ablation Generator EU Recall (2026-06-11), Intervascular Cardioroot Vascular Grafts May Fail Water Permeability Test (2026-08-12), and LeMait: Artegraft Vascular Graft Recall Due to Labeling Mix-Up (2026-02-10).